The effects of increased central serotonergic activity on psychophysiological parameters of human information processing.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders; Generalised anxiety disorder; Obsessive-compulsive disorders; Panic disorder
- Focus Pharmacodynamics
- 30 Apr 2011 Results published in the Psychiatry Research.
- 24 Mar 2009 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 19 Sep 2006 Status change